Syndax Pharmaceuticals In... (SNDX)
15.56
-0.08 (-0.51%)
At close: Mar 03, 2025, 3:59 PM
15.48
-0.50%
After-hours: Mar 03, 2025, 04:00 PM EST
Syndax Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 295.39M | 74.36M | 221.97M | 115.24M | 24.61M | 33.77M | 35.17M | 23.84M | 23.18M | 10.01M | 10.1M | 537K | 3.7M |
| Short-Term Investments | 282.19M | 410.04M | 217.97M | 177.82M | 35.17M | 47.14M | 94.81M | 81.49M | 64.11M | 2.2M | 4.16M | 91K | 613K |
| Long-Term Investments | 29.83M | 5.47M | n/a | 115K | 115K | n/a | 3.25M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 680K | 9.44M | n/a | 1.15M | 82K | 219K | 231K | 243K | 1.81M | 339K | 2.48M | 755K | 345K |
| Receivables | 1.23M | 4.06M | 429K | 175K | 116K | 253K | 377K | 306K | 258K | 35K | n/a | n/a | n/a |
| Inventory | n/a | -4.25M | 7.65M | 5.28M | 1.68M | 1.05M | -1.44M | 2.41M | 264K | 51K | n/a | n/a | n/a |
| Other Current Assets | 2.07M | 9.93M | 7.92M | 5.62M | 2.44M | 2.08M | 2.98M | 2.87M | 1.21M | 150K | 280K | 107K | 77K |
| Total Current Assets | 580.88M | 481.27M | 448.4M | 298.86M | 62.33M | 83.35M | 133.44M | 108.51M | 88.01M | 12.44M | 14.54M | 735K | 4.39M |
| Property-Plant & Equipment | 1.5M | 1.06M | 1.26M | 482K | 997K | 373K | 267K | 260K | 88K | 33K | 40K | 20K | 50K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 32M | 15.96M | 1.26M | 1.75M | 1.19M | 592K | 3.74M | 503K | 1.9M | 372K | 2.52M | 775K | 395K |
| Total Assets | 612.88M | 497.24M | 449.66M | 300.61M | 63.52M | 83.94M | 137.19M | 109.01M | 89.9M | 12.82M | 17.06M | 1.51M | 4.79M |
| Account Payables | 9.96M | 4.35M | 5.67M | 3.51M | 6.18M | 1.44M | 2.23M | 2.38M | 1.45M | 354K | 1.08M | 776K | 810K |
| Deferred Revenue | n/a | n/a | 12.76M | 1.52M | 1.52M | 1.52M | 1.57M | 1.22M | 1.22M | 3.38M | n/a | 2.41M | n/a |
| Short-Term Debt | 1.05M | 439K | 362K | 2.6M | 478K | n/a | n/a | n/a | n/a | 6.45M | n/a | 21.34M | 10.68M |
| Other Current Liabilities | 47.09M | 24.28M | 14.65M | 11.25M | 10.2M | 13.15M | 11.99M | 6.77M | 2.17M | 3.54M | 1.65M | 2.98M | 1.92M |
| Total Current Liabilities | 58.1M | 29.07M | 20.68M | 18.87M | 18.37M | 16.11M | 15.8M | 10.37M | 4.85M | 10.35M | 2.73M | 25.1M | 13.41M |
| Long-Term Debt | 588K | 722K | 20.61M | 17.93M | 419K | n/a | n/a | n/a | n/a | 7.43M | n/a | n/a | 8.66M |
| Other Long-Term Liabilities | n/a | n/a | n/a | 1K | 5K | 136K | 310K | 288K | 2.92M | 751K | 2.48M | 5.69M | 1.77M |
| Total Long-Term Liabilities | 588K | 722K | 20.61M | 29.55M | 13.56M | 14.79M | 17.07M | 14.51M | 18.36M | 8.19M | 2.48M | 5.69M | 10.44M |
| Total Liabilities | 58.68M | 29.79M | 41.29M | 48.42M | 31.93M | 30.89M | 32.87M | 24.87M | 23.2M | 18.53M | 5.21M | 30.8M | 23.84M |
| Total Debt | 1.64M | 1.16M | 20.97M | 20.54M | 897K | n/a | n/a | n/a | n/a | 13.88M | n/a | 21.34M | 19.34M |
| Common Stock | 8K | 7K | 6K | 5K | 3K | 2K | 2K | 2K | 1K | 1K | 1K | n/a | n/a |
| Retained Earnings | -902.4M | -693.04M | -543.7M | -568.63M | -495.47M | -439.42M | -366.11M | -305.29M | -259.68M | -159.8M | -135.71M | -79.05M | -68.9M |
| Comprehensive Income | 218K | -806K | 45K | -4K | n/a | -25K | -143K | 56K | 28K | -185K | -170K | -238K | n/a |
| Shareholders Equity | 554.2M | 467.45M | 408.37M | 252.19M | 31.6M | 53.05M | 104.32M | 84.14M | 66.7M | -5.72M | 11.85M | -29.29M | -19.05M |
| Total Investments | 312.02M | 406.92M | 217.97M | 177.82M | 35.17M | 47.14M | 98.05M | 81.49M | 64.11M | 2.2M | 4.16M | 91K | 613K |